Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin for Ocular Surface Wound Healing After Pterygium Excision
TCTR20260301003Phase 2Not yet recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in pterygium, Ocular surface wound (not a recognized disease name; see rationale), sponsored by Faculty of Medicine, Chulalongkorn University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
pterygiumOcular surface wound (not a recognized disease name; see rationale)
Beyond the preview
Go deeper on TCTR20260301003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260301003.